UnitedHealth Earnings Show Why It Is a Top Dow Stock

Photo of Chris Lange
By Chris Lange Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
UnitedHealth Earnings Show Why It Is a Top Dow Stock

© Courtesy of UnitedHealth Group

UnitedHealth Group Inc. (NYSE: UNH) released its third-quarter financial results before the markets opened on Tuesday. The company said that it had $3.41 in earnings per share (EPS) and $56.56 billion in revenue, which compares with consensus estimates of 3.29 in EPS and revenue of $56.34 billion. In the same period of last year, the managed health care giant said it had EPS of $2.66 on $50.32 billion in revenue.

During the quarter, UnitedHealthcare grew to serve 2.8 million more consumers year-over-year in the third quarter of 2018, with revenues growing by $5.2 billion, or 12.8%, to $45.9 billion. Revenue growth was driven by an increasing number of people served, greater membership growth in higher acuity programs, pricing to cover expected medical cost trends and resumption of the health insurance tax for 2018.

The company repurchased 1.9 million shares in the third quarter, bringing year-to-date purchases to 15.7 million shares for $3.65 billion. Dividends paid to shareholders were $866 million in the third quarter, reflecting the 20% increase in the company’s dividend rate in June 2018.

[nativounit]

Looking ahead to the full year, the company now expects to see EPS at $12.80, up from the previous range of $12.50 to $12.75. Consensus estimates call for $12.70 in EPS and $225.31 billion in revenue for the year.

David S. Wichmann, CEO of UnitedHealth, commented:

These results reflect our businesses delivering increased value at an accelerating pace to society and the millions of people we serve – one person at a time.

Shares of UnitedHealth traded up 2.6% early Tuesday at $266.96, with a consensus analyst price target of $295.05 and a 52-week range of $196.37 to $272.07.

[recirclink id=498951]

[wallst_email_signup]

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618